EnteroMedics obesity device gets venture financing

07/20/2006 | Twincities.com

EnteroMedics received $45.2 million in venture capital to develop clinical trials for its neuromodulation implant to spur weight loss in obese people, which the company aims to have ready in two to three years. The device is designed to block the vagus nerve, controlling the feeling of hunger and slowing digestion, which differs from the approach in Medtronic's and Cyberonics' devices, which work by stimulating the nerve to mimic the feeling of being full.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA